Memorandum from Dr Maycock to Bidwell regarding the application of a product licence into Factor VIII and coverage of Article 3 of the Medicines (Exemption from Licenses) (Special and Transitional Cases) Order 1971 (SI 1971No 1450) which apples to BPLs assembly of human plasma fractions.